Jim Simons Dare Bioscience, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 778,700 shares of DARE stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

778,700

Previous 762,900 2.07%

Holding current value

$3.03 Million

Previous $374,000 29.41%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.28 - $0.61 $4,424 - $9,638	15,800 Added 2.07%	778,700 $264,000
Q1 2024 May 13, 2024	BUY	$0.31 - $0.57 $13,485 - $24,794	43,500 Added 6.05%	762,900 $374,000
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.53 $14,093 - $25,758	48,600 Added 7.25%	719,400 $222,000
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.91 $22,089 - $43,699	-48,021 Reduced 6.68%	670,800 $310,000
Q2 2023 Aug 11, 2023	BUY	$0.91 - $1.05 $136,283 - $157,250	149,762 Added 26.32%	718,821 $654,000
Q1 2023 May 12, 2023	BUY	$0.87 - $1.36 $59,478 - $92,977	68,366 Added 13.65%	569,059 $592,000
Q4 2022 Feb 13, 2023	SELL	$0.82 - $12.6 $122,431 - $1.88 Million	-149,307 Reduced 22.97%	500,693 $416,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $12.48 $294,736 - $3.54 Million	283,400 Added 77.3%	650,000 $650,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.76 $250,285 - $468,619	266,261 Added 265.36%	366,600 $451,000
Q1 2022 May 13, 2022	BUY	$1.42 - $2.09 $142,481 - $209,708	100,339 New	100,339 $150,000
Q4 2021 Feb 11, 2022	SELL	$1.42 - $2.13 $460,122 - $690,183	-324,030 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.42 - $2.0 $357,044 - $502,880	251,440 Added 346.38%	324,030 $541,000
Q2 2021 Aug 13, 2021	SELL	$1.21 - $1.89 $967,779 - $1.51 Million	-799,818 Reduced 91.68%	72,590 $137,000
Q1 2021 May 13, 2021	BUY	$1.31 - $3.0 $215,774 - $494,139	164,713 Added 23.27%	872,408 $1.47 Million
Q4 2020 Feb 10, 2021	BUY	$0.96 - $1.51 $3,931 - $6,183	4,095 Added 0.58%	707,695 $948,000
Q3 2020 Nov 13, 2020	BUY	$0.98 - $1.52 $50,485 - $78,304	51,516 Added 7.9%	703,600 $703,000
Q2 2020 Aug 13, 2020	BUY	$0.84 - $1.11 $378,896 - $500,684	451,067 Added 224.39%	652,084 $645,000
Q1 2020 May 14, 2020	SELL	$0.79 - $1.7 $13,309 - $28,639	-16,847 Reduced 7.73%	201,017 $171,000
Q4 2019 Feb 13, 2020	BUY	$0.72 - $0.9 $3,789 - $4,736	5,263 Added 2.48%	217,864 $179,000
Q3 2019 Nov 13, 2019	SELL	$0.74 - $0.87 $5,065 - $5,955	-6,845 Reduced 3.12%	212,601 $166,000
Q2 2019 Aug 12, 2019	BUY	$0.79 - $1.66 $32,469 - $68,226	41,100 Added 23.05%	219,446 $187,000
Q1 2019 May 14, 2019	BUY	$0.73 - $2.1 $32,704 - $94,080	44,800 Added 33.55%	178,346 $250,000
Q4 2018 Feb 13, 2019	BUY	$0.63 - $1.12 $84,133 - $149,571	133,546 New	133,546 $95,000

Others Institutions Holding DARE

# of Institutions

Shares Held

7.13M

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $330M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account